These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 302361)
1. Relationship between dialyzer reuse and the presence of anti-N-like antibodies in chronic hemodialysis patients. Kaehny WD; Miller GE; White WL Kidney Int; 1977 Jul; 12(1):59-65. PubMed ID: 302361 [TBL] [Abstract][Full Text] [Related]
2. Dialyzer reuse following manual reprocessing with a new sterilant, RenNew-D. Gagnon R; Adkar V; Kaye M Artif Organs; 1987 Apr; 11(2):132-6. PubMed ID: 3593042 [TBL] [Abstract][Full Text] [Related]
3. Influence of reuse and of reuse sterilants on the first-use syndrome. Vanholder R; Ringoir S Artif Organs; 1987 Apr; 11(2):137-9. PubMed ID: 3496070 [TBL] [Abstract][Full Text] [Related]
4. Effect of dialyzer reuse on survival of patients treated with hemodialysis. Feldman HI; Kinosian M; Bilker WB; Simmons C; Holmes JH; Pauly MV; Escarce JJ JAMA; 1996 Aug; 276(8):620-5. PubMed ID: 8773634 [TBL] [Abstract][Full Text] [Related]
5. Hemodialyzer Reuse and Gram-Negative Bloodstream Infections. Edens C; Wong J; Lyman M; Rizzo K; Nguyen D; Blain M; Horwich-Scholefield S; Moulton-Meissner H; Epson E; Rosenberg J; Patel PR Am J Kidney Dis; 2017 Jun; 69(6):726-733. PubMed ID: 27940061 [TBL] [Abstract][Full Text] [Related]
6. Anti-Nform antibody in hemodialysis patients. Ng YY; Chow MP; Wu SC; Lyou JY; Harris DC; Huang TP Am J Nephrol; 1995; 15(5):374-8. PubMed ID: 7503135 [TBL] [Abstract][Full Text] [Related]
8. Characteristics and treatment of patients not reusing dialyzers in reuse units. Okechukwu CN; Orzol SM; Held PJ; Pereira BJ; Agodoa LY; Wolfe RA; Port FK Am J Kidney Dis; 2000 Nov; 36(5):991-9. PubMed ID: 11054356 [TBL] [Abstract][Full Text] [Related]
10. Influence of erythropoietin treatment on dialyzer reuse. Kes P; Reiner Z; Starcević B; Ratković-Gusić I Blood Purif; 1997; 15(2):77-83. PubMed ID: 9087814 [TBL] [Abstract][Full Text] [Related]
11. Anti-N-like and anti-Form red cell antibodies in chronic hemodialysis patients. Fonseca HE; Chiba AK; Junior AF; Draibe SA; Bordin JO Ren Fail; 2004 Sep; 26(5):553-6. PubMed ID: 15526914 [TBL] [Abstract][Full Text] [Related]
12. Dialyzer reprocessing with peroxyacetic acid as sole cleansing and sterilizing agent. Kes P; Reiner Z; Ratković-Gusić I Acta Med Croatica; 1997; 51(2):87-93. PubMed ID: 9204593 [TBL] [Abstract][Full Text] [Related]
13. Effect of dialyzer reprocessing methods on complement activation and hemodialyzer-related symptoms. Dumler F; Zasuwa G; Levin NW Artif Organs; 1987 Apr; 11(2):128-31. PubMed ID: 3036049 [TBL] [Abstract][Full Text] [Related]
14. Association of dialyzer reuse and hospitalization rates among hemodialysis patients in the US. Feldman HI; Bilker WB; Hackett M; Simmons CW; Holmes JH; Pauly MV; Escarce JJ Am J Nephrol; 1999; 19(6):641-8. PubMed ID: 10592357 [TBL] [Abstract][Full Text] [Related]
15. Formation of anti-N-like antibodies in dialysis patients: effect of different methods of dialyzer rinsing to remove formaldehyde. Lewis KJ; Dewar PJ; Ward MK; Kerr DN Clin Nephrol; 1981 Jan; 15(1):39-43. PubMed ID: 6971198 [TBL] [Abstract][Full Text] [Related]
16. Antibody responses to hemodialysis-related antigens in chronic hemodialysis patients. Dolovich J; Evans S; Baurmeister U; Schulze H; Ali M; Shimizu A Artif Organs; 1987 Apr; 11(2):93-6. PubMed ID: 3593051 [TBL] [Abstract][Full Text] [Related]
18. [Effect of re-utilization of cuprophan capillary dialysers with different liquids on their biocompatibility and effectiveness of elimination]. Orłowski A; Szepietowski T Polim Med; 1992; 22(1-2):59-72. PubMed ID: 1461837 [TBL] [Abstract][Full Text] [Related]